4519.T-15.09%23.6%
ALNY-46.58%23.6%
ARWR+432.86%23.6%
WVE-30.64%23.6%
2257.HK-54.21%4.7%
NVO-1.93%1.0%
As of Aug 6, 2026, 4:25 AM ET
GLP-1 Long '26: RNA Fat Redistribution Constituents
Alnylam Pharmaceuticals, Inc.ALNY | 23.6% | 4.44% | -15.84% | -26.94% | 11.29% | -42.48% | -31.30% | -14.28% | -46.58% | $30.54B |
Arrowhead Pharmaceuticals, Inc.ARWR | 23.6% | -2.99% | 1.53% | 0.42% | 2.67% | 30.91% | 37.36% | 584.87% | 432.86% | $12.24B |
Chugai Pharmaceutical Co., Ltd.4519.T | 23.6% | 0.12% | -5.38% | -8.45% | -3.52% | -18.86% | -36.03% | -4.41% | -15.09% | $69.34B |
Wave Life Sciences Ltd.WVE | 23.6% | -1.17% | 2.07% | -6.17% | 7.62% | -65.12% | -57.43% | -21.66% | -30.64% | $1.17B |
Sirnaomics Ltd.2257.HK | 4.7% | -2.44% | -0.25% | -14.56% | 0.76% | -48.38% | -42.81% | 14.75% | -54.21% | $55.5M |
Novo Nordisk A/SNVO | 1.0% | 0.51% | -8.75% | -9.65% | -5.47% | -12.53% | 18.84% | -34.78% | -1.93% | $197.88B |
| Theme return | — | -0.02% | -4.25% | -7.46% | 5.53% | -24.92% | -22.09% | 59.24% | 16.10% | — |
| Average | 16.7% | -0.25% | -4.44% | -10.89% | 2.23% | -26.08% | -18.56% | 87.42% | 47.40% | $51.87B |
| Median | 23.6% | -0.52% | -2.81% | -9.05% | 1.72% | -30.67% | -33.66% | -9.34% | -22.86% | $21.39B |
| Std Dev | 9.8% | 2.44% | 6.39% | 8.45% | 5.86% | 31.02% | 34.38% | 222.99% | 173.28% | $69.41B |
| Min | 1.0% | -2.99% | -15.84% | -26.94% | -5.47% | -65.12% | -57.43% | -34.78% | -54.21% | $55.5M |
| Max | 23.6% | 4.44% | 2.07% | 0.42% | 11.29% | 30.91% | 37.36% | 584.87% | 432.86% | $197.88B |
| % Positive Tickers | 50.00% | 33.33% | 16.67% | 66.67% | 16.67% | 33.33% | 33.33% | 16.67% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
GLP-1 Long '26: RNA Fat Redistribution tracks 6 publicly listed stocks in this theme: 2257.HK, 4519.T, ALNY, ARWR, NVO, WVE. See the constituent table for details.